We are live on ! Find out more
Formula Growth

Formula Growth Portfolio holdings

AUM $284M Turnover 33.14%
1-Year Est. Return 54.56%
This Fund
S&P 500
This Quarter Est. Return
+39.63%
1 Year Est. Return
+54.56%
3 Year Est. Return
+117.67%
5 Year Est. Return
+78.26%
10 Year Est. Return
+276.27%
AUM
$284M
AUM Growth
+$62.7M
Cap. Flow
+$6.37M
Cap. Flow %
2.24%
Top 10 Hldgs %
22.84%
Holding
169
New
32
Increased
28
Reduced
43
Closed
24
Avg Time Held
2.8 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$3.23M
2
KVYO icon
Klaviyo
KVYO
+$2.49M
3
GH icon
Guardant Health
GH
+$2.1M
4
EQPT icon
EquipmentShare.com Inc
EQPT
+$1.66M
5
AVEX icon
AEVEX Corp
AVEX
+$1.53M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$6.75M
2
NOK icon
Nokia
NOK
+$3.54M
3
FPS icon
Forgent Power Solutions
FPS
+$2.4M
4
NAVN icon
Navan Inc
NAVN
+$1.85M
5
ARCB icon
ArcBest
ARCB
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 31.94%
2 Industrials 26.42%
3 Healthcare 16.98%
4 Consumer Discretionary 11.41%
5 Financials 4.41%

No holdings matched the selected filter criteria.

Similar funds

Formula Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Formula Growth held 169 positions worth $284M, up 28% from $222M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Formula Growth's Q2 2026 filing shows 32 new, 28 increased, 43 reduced and 24 closed positions. Its largest new stake was Guardant Health: 19,300 shares worth $2.9M. The largest sale was Micron Technology, an estimated $6.75M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Formula Growth's largest Q2 2026 buy was Guardant Health: 19,300 shares worth $2.9M.
  • Formula Growth added most to Calix in Q2 2026, an estimated $3.23M increase.
  • Formula Growth's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $6.75M.
  • Formula Growth fully exited Navan Inc in Q2 2026, selling an estimated $1.85M.
  • Formula Growth's ten largest holdings make up 23% of its $284M portfolio in Q2 2026.
  • Formula Growth opened 32 new positions and closed 24 in Q2 2026.
  • Formula Growth's portfolio value rose 28% quarter-over-quarter to $284M.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.